TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 11.30
+0.30 (2.73%)
At close: Dec 5, 2025
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 8.04 billion as of December 5, 2025. Its market cap has decreased by -15.43% in one year.
Market Cap
8.04B
Enterprise Value
7.26B
Revenue
38.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.30
Market Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 8.04B, a decrease of -80.88%. That is a compound annual growth rate of -12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.04B | -2.14% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | 16.38B | 24.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.21B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.68B |
| Center Laboratories | 28.03B |